Arkolith/Insider Trading/EW/Form 4

Bobo Donald E JR

CVP,Strategy/Corp DevelopmentEdwards Lifesciences Corp (EW) · full profile →Form 4 · filed May 8, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 8, 2026Tax withholding(F)1K$82.76$86K27K
May 7, 2026Grant(A)8K—$029K
May 7, 2026Tax withholding(F)831$83.20$69K28K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 7, 2026Grant(A)44K—$044K
May 7, 2026Grant(A)8K—$08K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001225208-26-005048) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML